Stock Earnings

Question 1

What are Proteomics International Laboratories Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Proteomics International Laboratories Ltd has a total asset of $14, Net loss of $-8

Question 2

What are the key financial ratios for PIQLF?

Accepted Answer

Proteomics International Laboratories Ltd's Current ratio is 14, has a Net margin is -266.66, sales per share of $0.02.

Question 3

How is Proteomics International Laboratories Ltd's revenue broken down by segment or geography?

Accepted Answer

Proteomics International Laboratories Ltd largest revenue segment is Analytical Services, at a revenue of 876,890 in the most earnings release.For geography, Australia and New Zealand is the primary market for Proteomics International Laboratories Ltd, at a revenue of 782,649.

Question 4

Is Proteomics International Laboratories Ltd profitable?

Accepted Answer

no, according to the latest financial statements, Proteomics International Laboratories Ltd has a net loss of $-8

Question 5

Does Proteomics International Laboratories Ltd have any liabilities?

Accepted Answer

yes, Proteomics International Laboratories Ltd has liability of 1

Question 6

How many outstanding shares for Proteomics International Laboratories Ltd?

Accepted Answer

Proteomics International Laboratories Ltd has a total outstanding shares of 163.52

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	3	3	3	3	1	1
Revenue Growth (YoY)	0%	0%	0%	200%	0%	0%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	9	9	8	8	7	4
Research & Development	--	--	--	--	--	--
Operating Expenses	11	11	10	9	6	4
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-8	-8	-6	-6	-4	-2
Income Tax Expense	0	0	0	0	0	0
Net Income	-8	-8	-6	-6	-4	-2
Net Income Growth	33%	33%	0%	50%	100%	100%
Shares Outstanding (Diluted)	118.98	134.26	125.84	116.45	105.53	101.7
Shares Change (YoY)	-6%	7%	8%	10%	4%	16%
EPS (Diluted)	-0.06	-0.06	-0.05	-0.05	-0.04	-0.02
EPS Growth	19%	19%	-4%	13%	68%	41%
Free Cash Flow	-6	-6	-5	-6	-3	-2
Free Cash Flow Per Share	-0.05	-0.04	-0.03	-0.05	-0.02	-0.01
Gross Margin	--	--	--	--	--	--
Operating Margin	-266.66%	-266.66%	-200%	-200%	-400%	-300%
Profit Margin	-266.66%	-266.66%	-200%	-200%	-400%	-200%
Free Cash Flow Margin	-200%	-200%	-166.66%	-200%	-300%	-200%
EBITDA	-8	-8	-6	-6	-4	-3
EBITDA Margin	-266.66%	-266.66%	-200%	-200%	-400%	-300%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-8	-8	-6	-6	-4	-3
EBIT Margin	-266.66%	-266.66%	-200%	-200%	-400%	-300%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Proteomics International Laboratories Ltd (PIQLF) Price

PIQLF Stock Price Chart

PIQLF Income

Follow-Up Questions